An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. - Stringer-Reasor EM; May JE; Olariu E; Caterinicchia V; Li Y; Chen D; Della Manna DL; Rocque GB; Vaklavas C; Falkson CI; Nabell LM; Acosta EP; et al. (Breast cancer research : BCR, 2021)